Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Science and Society
  • Published:

Genetic profiling of newborns: ethical and social issues

Abstract

Identifying genetic factors that could reliably predict health risks for individuals has the potential to bring great health benefits, both for the individuals concerned and for health-care providers. Genetic profiling at birth would allow a person's genome to be analysed at an early stage, and the data electronically stored for future use. However, although this might seem like an attractive proposition, it carries with it serious ethical and social concerns that would need to be addressed if the genetic profiling of newborns were ever to be considered on a population-wide basis.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bell, J. Predicting disease using genomics. Nature 429, 453–456 (2004).

    Article  CAS  PubMed  Google Scholar 

  2. Bentley, D. R. Genomes for medicine. Nature 429, 440–445 (2004).

    Article  CAS  PubMed  Google Scholar 

  3. GeneWatch UK. Pharmacogenetics: better, safer medicines? Briefing Number 23 [online], <http://www.genewatch.org/Publications/Briefs/Brief23.pdf> (2003).

  4. Evans, W. E. & Relling, M. V. Moving towards individualized medicine with pharmacogenomics. Nature 429, 464–468 (2004).

    Article  CAS  PubMed  Google Scholar 

  5. Department of Health. Our Inheritance, Our Future — Realising the potential of genetics in the NHS. HMSO document [online], <http://www.dh.gov.uk/assetRoot/04/01/92/39/04019239.pdf> (2003).

  6. Human Genetics Commission. Profiling the newborn: a prospective gene technology? Human Genetics Commission document [online], <http://www.hgc.gov.uk/UploadDocs/Contents/Documents/Final%20Draft%20of%20Profiling%20Newborn%20Report%2003%2005.pdf> (2005).

  7. Clarke, A. The genetic testing of children. Working Party of the Clinical Genetics Society (UK). J. Med. Genet. 31, 785–797 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kroese, M., Zimmern, R. L. & Sanderson, S. Genetic Tests and their evaluation: Can we answer the key questions? Genet. Med. 6, 475–480 (2004).

    Article  PubMed  Google Scholar 

  9. Green, N. S. & Pass, K. N. Neonatal screening by DNA microarray: spots and chips. Nature Rev. Genet. 6, 147–151 (2005).

    Article  CAS  PubMed  Google Scholar 

  10. Laberge, C., Kharaboyan, L. & Avard, D. Newborn screening, banking, and consent. HumGen GenEdit archives [online], <http://www.humgen.umontreal.ca/int/GE/en/2004-3.pdf> (2004).

    Google Scholar 

  11. Shendure, J. et al. Accurate multiplex polony sequencing of an evolved bacterial genome. Science 309, 1728–1732 (2005).

    Article  CAS  PubMed  Google Scholar 

  12. Margulies, M. et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437, 376–380 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kling, J. The search for a sequencing thoroughbred. Nature Biotechnol. 23, 1333–1335 (2005).

    Article  CAS  Google Scholar 

  14. US National Institutes of Health. NHGRI seeks next generation of sequencing technologies. NIH News Release [online], <http://www.genome.gov/12513210> (14 October 2004).

  15. The International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299–1320 (2005).

  16. US National Institutes of Health. Additional genotyping for the human haplotype map. NIH Research Funding Announcement [online], <http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-04-005.html> (16 April 2004).

  17. Hirschhorn, J. N. & Daly, M. J. Genome-wide association studies for common diseases and complex traits. Nature Rev. Genet. 6, 95–108 (2005).

    Article  CAS  PubMed  Google Scholar 

  18. Holtzman N. A. & Marteau, T. M. Will genetics revolutionize medicine? N. Engl. J. Med. 343, 141–144 (1999).

    Article  Google Scholar 

  19. Beutler, E. et al. Penetrance of the 845G>A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359, 211–218 (2002).

    Article  PubMed  Google Scholar 

  20. Beutler, E. The HFE Cys282Tyr mutation as a necessary but not sufficient cause of hereditary hemochromatosis. Blood 101, 3347–3350 (2003).

    Article  CAS  PubMed  Google Scholar 

  21. Feder, J. N. et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet. 13, 399–408 (1996).

    Article  CAS  PubMed  Google Scholar 

  22. Jazwinska, E. C. et al. Haemochromatosis and HLA-H. Nature Genet. 14, 249–251 (1996).

    Article  CAS  PubMed  Google Scholar 

  23. EUROGAPP PROJECT 1999–2000 Public and Professional Policy Committee (PPPC). Population genetic screening programmes: proposed recommendations of the European Society of Human Genetics. Eur. J. Hum. Genet. 8, 998–1000 (2000).

  24. Carlson, C. S. et al. Mapping complex disease loci in whole-genome association studies. Nature 429, 446–452 (2004).

    Article  CAS  PubMed  Google Scholar 

  25. Holm, S. Informed consent and the bio-banking of material from children. Genomics Society Policy 1, 16–26 (2005).

    Article  Google Scholar 

  26. General Medical Council. Seeking patients' consent: the ethical considerations. Genetic Medical Council web page on consent [online], <http://www.gmc-uk.org/guidance/library/consent.asp> (1999).

  27. Burke, W. & Emery, J. Genetics education for primary-care providers. Nature Rev. Genet. 3, 561–566 (2002).

    Article  CAS  PubMed  Google Scholar 

  28. World Health Organization. Proposed international guidelines on ethical issues in medical genetics and genetics services. WHO Human Genetics Programme [online], <http://www.who.int/genomics/publications/en/ethicalguidelines1998.pdf> (1998).

  29. United Nations Educational, Scientific and Cultural Organization. Draft International Declaration on Human Genetic Data. Submission to the General Conference, 32nd session [online], <http://unesdoc.unesco.org/images/0013/001312/131204e.pdf> (2003).

  30. Human Genetics Commission. Inside information: balancing interests in the use of personal genetic data. Human Genetics Commission document [online], <http://www.hgc.gov.uk/UploadDocs/DocPub/Document/ insideinformation_summary.pdf> (2002).

  31. Sevick, M. A. et al. Genetic testing of children for late-onset disease. Camb. Q. Healthc. Ethics 14, 47–56 (2005).

    Article  PubMed  Google Scholar 

  32. Michie, S. & Marteau, T. M. Predictive genetic testing in children: the need for psychological research. Br. J. Health Psychol. 1, 3–14 (1996).

    Article  Google Scholar 

  33. Marteau, T. M. & Lerman, C. Y. Genetic risk and behavioural change. BMJ 322, 1056–1059 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Fryer, A. Inappropriate genetic testing of children. Arch. Dis. Childhood 83, 283–285 (2000).

    Article  CAS  Google Scholar 

  35. Genetic Interest Group. GIG responses to the UK Clinical Genetics Society report 'The genetic testing of children'. J. Med. Genet. 32, 490–494 (1995).

  36. McLean, S. A. M. in The Genetic Testing of Children (ed. Clarke, A.) 17–26 (Bios Scientific, Oxford, 1998).

    Google Scholar 

  37. Laird, L., Dezateux, C. & Anionwu, E. N. Neonatal screening for sickle cell disorders: what about the carrier infants? BMJ 313, 407–411 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Marteau, T. & Anionwu, E. N. in The Troubled Helix: Social and Psychological Implications of the New Genetics (eds Marteau, T & Richard, M. P. M.) 123–139 (Cambridge Univ. Press, 1996)..

    Google Scholar 

  39. Clark, A. The genetic testing of children. Working Party of the Clinical Genetics Society (UK). J. Med. Genet. 31, 785–797 (1994).

    Article  Google Scholar 

  40. Austoker, J. Gaining informed consent for screening. BMJ 319, 722–723 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Billings PR, et al. Discrimination as a consequence of genetic testing. Am. J. Hum. Genet. 50, 476–482 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  42. GeneWatch UK. Bar-coding babies: good for health? Briefing Number 27 [online], <http://www.genewatch.org/Publications/Briefs/brief27.pdf> (2004).

  43. Sulston, J. & Harris, J. Genetic equity. Nature Rev. Genet. 5, 796–800 (2004).

    Article  PubMed  Google Scholar 

  44. Melzer D. & Zimmern, R. Genetics and medicalisation. BMJ 324, 863–864 (2002).

    Article  PubMed  PubMed Central  Google Scholar 

  45. European Diagnostic Manufacturers Association Public Relations Committee. Genetic testing, Position paper. EDMA web site [online], <http://www.edma-ivd.be/Position_papers/Genetic_Testing_PP_FINAL_24Oct03.doc> (24 October 2003).

  46. Petersen, A. Counselling the genetically 'at risk': the poetics and politics of 'non-directiveness'. Health Risk Soc. 1, 253–265 (1999).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Related links

Related links

Databases

OMIM

Alzheimer disease

congenital hypothyroidism

cystic fibrosis

Duchenne muscular dystrophy

galactosaemia

Huntington disease

phenylketonuria

FURTHER INFORMATION

Human Genetics Commission homepage

Human Genome Project

International HapMap Project

The SNP Consortium web site

UK National Screening Committee homepage

Glossary

Galactosaemia

A rare autosomal recessive disorder. It is an inability to use galactose, which accumulates in the blood. Untreated affected infants fail to thrive and become mentally retarded, but if galactose is eliminated from the diet growth and development can be normal.

Guthrie cards

Cards that are used in several countries in the screening of newborns for more than 30 genetic disorders. Assays for specific analytes are carried out on proteins that have been reconstituted from dried blood spots.

Haemochromatosis

A hereditary disease that is characterized by improper processing of iron in the body. There is excessive absorption and storage of iron in affected individuals, which leads to damage of many organs, including the liver and endocrine glands.

Haemoglobinopathies

Inherited disorders of haemoglobin that affect the properties of red blood cells.

Huntingdon disease

(Also known as Huntington chorea.) A rare, inherited disease of the CNS, which is characterized by progressive dementia, abnormal posture and involuntary movements. The typical age of onset is between 30 and 50 years.

International Hapmap Project

A major international research effort to construct a resource that will facilitate future studies that relate human genetic variation to health and disease by understanding the haplotype structure of the human genome.

Munchausen syndrome by proxy

Munchausen syndrome is a psychological disorder that is characterized by the repeated fabrication or causation of disease symptoms or trauma for the purpose of gaining medical attention or treatment. In the case of Munchausen syndrome by proxy, it is a caregiver, usually a parent, who feigns or induces an illness in another person, usually her or his child.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Almond, B. Genetic profiling of newborns: ethical and social issues. Nat Rev Genet 7, 67–71 (2006). https://doi.org/10.1038/nrg1745

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nrg1745

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing